PHYSIMED
ActiveSummary
The computed 12-month bankruptcy probability of PHYSIMED is 8.4% (elevated). For PHYSIMED, at least two filing cycles of the annual accounts are missing. The 2022 annual accounts show equity of €523,146 and a net result of -€16,942. Equity remains stable across the filed financial years (±2% per year). Its solvency ranks better than 93% of 1,074 sector peers (NACE 71, financial year 2022). The company has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals.
Directors
Directors
No directors read yet: 0 of 2 Gazette acts processed. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.